These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35781038)

  • 1. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer.
    Gould LE; Pring ET; Drami I; Moorghen M; Naghibi M; Jenkins JT; Steele CW; Roxburgh CS
    Int J Surg; 2022 Aug; 104():106738. PubMed ID: 35781038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
    Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT
    Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer.
    Aiba T; Uehara K; Tsuyuki Y; Ogura A; Murata Y; Mizuno T; Yamaguchi J; Kokuryo T; Yokoyama Y; Ebata T
    Eur J Surg Oncol; 2022 Dec; 48(12):2502-2508. PubMed ID: 35768314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review to Assess Resection Margin Status After Abdominoperineal Excision and Pelvic Exenteration for Rectal Cancer.
    Simillis C; Baird DL; Kontovounisios C; Pawa N; Brown G; Rasheed S; Tekkis PP
    Ann Surg; 2017 Feb; 265(2):291-299. PubMed ID: 27537531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in outcome measurement and reporting in studies of pelvic exenteration for locally advanced and recurrent rectal cancer: a systematic review.
    Brown KGM; Pisaniello J; Ng KS; Solomon MJ; Sutton PA; Hatcher S; Steffens D
    Colorectal Dis; 2024 Feb; 26(2):272-280. PubMed ID: 38131647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
    Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
    Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.
    van Rees JM; Visser E; van Vugt JLA; Rothbarth J; Verhoef C; van Verschuer VMT
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34672343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes.
    Mehta AM; Hellawell G; Burling D; Littler S; Antoniou A; Jenkins JT
    Tech Coloproctol; 2018 Sep; 22(9):663-671. PubMed ID: 30306276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
    PelvEx Collaborative
    Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 18. Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?
    Palma CA; van Kessel CS; Solomon MJ; Leslie S; Jeffery N; Lee PJ; Austin KKS
    Eur J Surg Oncol; 2023 Jul; 49(7):1250-1257. PubMed ID: 36658054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
    van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
    Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.